文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

撤回：勘误：丹参酮IIA联合顺铂通过下调NF-κB/COX-2/VEGF通路抑制食管鳞状细胞癌

Retraction: Corrigendum: Tan IIA Combined With DDP Inhibits Esophageal Squamous Cell Carcinoma Down-Regulating the NF-kB/COX-2/VEGF Pathway.

出版信息

Front Oncol. 2021 Jun 24;11:721663. doi: 10.3389/fonc.2021.721663. eCollection 2021.

DOI:10.3389/fonc.2021.721663

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8265271/

Abstract

[This retracts the article DOI: 10.3389/fonc.2021.670798.].

摘要

[本文撤回文章DOI：10.3389/fonc.2021.670798。]

相似文献

1

Retraction: Corrigendum: Tan IIA Combined With DDP Inhibits Esophageal Squamous Cell Carcinoma Down-Regulating the NF-kB/COX-2/VEGF Pathway.撤回：勘误：丹参酮IIA联合顺铂通过下调NF-κB/COX-2/VEGF通路抑制食管鳞状细胞癌

Front Oncol. 2021 Jun 24;11:721663. doi: 10.3389/fonc.2021.721663. eCollection 2021.

2

Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway.撤稿声明：丹参酮IIA和顺铂联合通过下调NF-κB/COX-2/VEGF通路抑制食管鳞状细胞癌

Front Oncol. 2021 Jun 29;11:721658. doi: 10.3389/fonc.2021.721658. eCollection 2021.

3

Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway.勘误：丹参酮IIA和顺铂联合通过下调NF-κB/COX-2/VEGF通路抑制食管癌

Front Oncol. 2021 Apr 6;11:670798. doi: 10.3389/fonc.2021.670798. eCollection 2021.

4

Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway.丹参酮IIA和顺铂联合通过下调NF-κB/COX-2/VEGF通路抑制食管癌

Front Oncol. 2020 Sep 10;10:1756. doi: 10.3389/fonc.2020.01756. eCollection 2020.

5

Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway.勘误：氯喹通过靶向CXCR4-STAT3通路抑制食管鳞状细胞癌细胞的干性。

Front Oncol. 2022 Feb 24;12:860158. doi: 10.3389/fonc.2022.860158. eCollection 2022.

6

Corrigendum: TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma.勘误：瞬时受体电位通道蛋白1（TRPC1）抑制细胞增殖/侵袭，可预测食管鳞状细胞癌的较好预后。

Front Oncol. 2021 Oct 6;11:767805. doi: 10.3389/fonc.2021.767805. eCollection 2021.

7

Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.丹参酮 IIA 通过抑制 IL-6/STAT3/NF-kB 信号通路抑制乳腺癌干细胞的体外和体内生长。

J Cell Biochem. 2013 Sep;114(9):2061-70. doi: 10.1002/jcb.24553.

8

Corrigendum: Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma.勘误：安罗替尼联合放化疗在食管鳞状细胞癌中显示出显著的治疗效果。

Front Oncol. 2020 Nov 20;10:583499. doi: 10.3389/fonc.2020.583499. eCollection 2020.

9

Retraction: STAT3 Promotes Invasion and Aerobic Glycolysis of Human Oral Squamous Cell Carcinoma Inhibiting FoxO1.撤回声明：信号转导和转录激活因子3通过抑制叉头框蛋白O1促进人口腔鳞状细胞癌的侵袭及有氧糖酵解。

Front Oncol. 2021 Sep 7;11:761874. doi: 10.3389/fonc.2021.761874. eCollection 2021.

10

Inhibits Cell Proliferation and Migration and Promotes Apoptosis via the CTHRC1/AKT/ERK Pathway in Esophageal Squamous Cell Carcinoma [Retraction].通过CTHRC1/AKT/ERK途径抑制食管鳞状细胞癌的细胞增殖和迁移并促进凋亡[撤回]

Onco Targets Ther. 2023 Oct 11;16:817-818. doi: 10.2147/OTT.S443969. eCollection 2023.

引用本文的文献

1

Current and future perspectives on the regulation and functions of miR-545 in cancer development.miR-545在癌症发展中的调控作用及功能的当前与未来展望

Cancer Pathog Ther. 2023 Sep 5;2(3):142-154. doi: 10.1016/j.cpt.2023.09.001. eCollection 2024 Jul.